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INTRODUCTION 
Nanotechnology is considered to be an emerging, 
disruptive technology that will have significant impact in 
all industrial sectors and across-the-board applications in 
cancer research. There has been tremendous investment 
in this area and an explosion of research and 
development efforts in recent years, particularly in the 
area of cancer research 1.Cancer remains one of the 
world’s most devastating diseases, with more than 10 
million new cases every year. However, mortality has 
decreased in the past two years owing to better 
understanding of tumour biology and improved 
diagnostic devices and treatments. Current cancer 
treatments include surgical intervention, radiation and 
chemotherapeutic drugs, which often also kill healthy 
cells and cause toxicity to the patient 2.  
Breast cancer, colorectal cancer, lung cancer, liver 
cancer and stomach cancer are some of the major types 
of cancer existing today. Deaths from cancer are 
continuously rising worldwide with a projection of about 
12 million deaths from cancer in 2030. Thereby, over the 
past few years, tremendous attention has been given to 
the cancer related research and developments. There has 
been an outstanding progress in the basic cancer biology. 
Many institutions, pharmaceutical and biotechnological 
industries have focused on cancer as their main target in 
their research and development departments3. The 
chemotherapeutic treatment of cancer has undergone 
revolution in the past 5-10 years with a variety of new 
drugs and regimens being either approved or under 
investigations. In the area of targeted delivery, the 
colonic region of GI tract is the one that has been 
embraced by scientists and is being extensively 
investigated over the past 2 decades. Targeting of drugs 
to specific sites of action provides several advantages 
over non-targeted drugs. A drugs needs to be protected 
from degradation, release and or absorption in the upper 
portion of GI tract and then to ensure abrupt or 
controlled release in the proximal colon while targeting 
drugs to colon 4. 
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ABSTRACT 
Nanotechnology has achieved the status as one of the vital research endeavors of 21stcentury, which may be called as “Nano-
Century” with nanotechnology making its presence felt in different spheres of lives. Nanotechnology may be defined as the 
creation of materials, drugs and devices that are used to manipulate matter of size in the range of 1-100nm. Nanotechnology 
has found its applications in many fields related to medicine including novel drug delivery systems. Many different types of 
nanosystems have been utilized in diagnostics and therapeutics of various diseases. To subside the disadvantages of 
conventional cancer therapeutics, nanotechnology has been given considerable attention. The purpose of this expert review is 
to discuss the impact of nanotechnology in the treatment of the cancer. These have been applied to improve drug delivery and 
to overcome some of the problems of drug delivery in cancer. Current nanotechnology platforms for cancer therapeutics 
encompass a vast array of nanomaterials and nanodevices. This review will focus on seven of the most prominent and most 
widely studied:  polymeric nanoparticles, nanoshells, carbon nanotubes, dendrimers, quantum dots, superparamagnetic 
nanoparticles, and liposomes. All of these nanotechnology platforms can be multifunctional, so they are frequently touted as 
“smart” or “intelligent.” It is concluded how nanotechnology can help solve one of the most challenging and longstanding 
problems in medicine, which is how to eliminate cancer without harming normal body tissue. 
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Many developed innovative nanotechnology platforms, 
such as polymeric nanoparticles, liposomes, dendrimers, 
nanoshells, carbon nanotubes, quantum dots, nanowires, 
cantilevers, superparamagnetic nanoparticles, have been 
applied to the effective delivery of specific anticancer 
drugs , including small molecular weight drugs and 
macro molecules (protein, peptides or genes) 5. 
Nanotechnology is defined as the study and use of 
structures between 1 nanometer and 100 nanometers in 
size. Nanotechnology is the combined effect of material 
sciences, microelectronics, mechanical, electrical, 
chemical engineering, and biological screening. 
Nanotechnologies are the design, production, 
characterization, and application of structures, devices 
and systems by controlling size and shape at nanometer 
scale. In modern scenario nanotechnology is used to 
provide more accurate  and  timely  medical  information  
for diagnosing disease, and miniature devices that can 
administer treatment automatically if required. It is used 
worldwide in the treatment of Cancer like precarious 
diseases. This article overviewed current 
nanotechnologies for cancer therapy, focusing on the 
wide variety of nano-technological platforms for 
anticancer drug delivery 6.  
 
 
Figure 1: Types of nanotechnology used for drug delivery and targeting 
 
NANO-TECHNOLOGICAL APPROACHES FOR 
TUMOUR TARGETING  
a. Polymeric Nanoparticles 
Generally, polymers that are used for preparation of 
nanoparticles fall into two major categories: natural 
polymers and synthetic polymers. A number of natural 
polymers such as heparin, dextran, albumin, gelatine, 
alginate, collagen, and chitosan have been intensively 
investigated. Synthetic polymers including polyethylene 
glycol (PEG), polyglutamic acid (PGA), polylactic acid 
(PLA), polycarprolactone (PCL) and N-(2-
hydroxypropyl)-methacrylamide copolymer (HPMA) 
have been exploited as well. General requirements for 
those polymers are biocompatibility, biodegradability, 
and their capacity to be functionalized 7. The polymeric 
nanoparticle consists of two parts, a hydrophobic core 
which serves as the container for anticancer agents and a 
hydrophilic shell which stabilizes the nanoparticle in 
aqueous environments. The drug can be loaded into 
polymeric nanoparticles through two methods: by 
physical entrapment or by chemical conjugation. A 
hydrophobic interaction between the core of the 
polymeric nanoparticle and the drug molecule allow the 
drug to be entrapped in the nanoparticle core 8, 9. 
 
Figure 2: Polymeric Nanoparticles 
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b. Liposomes 
 
Figure 3: Liposomes 
Liposomes are the simplest forms of nanovectors which 
are made up of lipids enclosing water core. They have 
found applications in various cancer indications 10. With 
the aid of over expression of fenestrations in cancer 
neovasculature, they increase the drug concentration at 
the tumor sites (passive targeting). In passive targeting, 
the drug is targeted to the target site passively owing to 
the physiological conditions of the body. Various 
Doxorubin encapsulated liposomal formulations have 
been clinically utilized for the treatment of Kaposi’s 
sarcoma, breast cancer and refractory ovarian cancer 11. 
They were developed to improve therapeutic index of the 
conventional Doxorubin chemotherapy while 
maintaining its antitumor activity. Similarly, S. 
Kommareddy et al have shown effective utilization of 
gelatin based nanovectors in tumors. Here, PEG 
modified gelatin based nanovectors were used as safe 
and effective vehicle for the delivery of systemically 
administered genes for tumors. Ruthenium and 
complexes of several other heavy metals have shown 
potential applications in cancer therapeutics. Lipid based 
nanovectors containing such complexes have also been 
put forth as a potential route in cancer 12. 
c. Dendrimers 
Dendrimers are nano-sized, radially symmetric 
molecules with well-defined, homogeneous and 
monodisperse structure consisting of tree-like arms or 
branches. With the size ranging from 1 to 10 nm, 
dendrimers with different chemical structures and 
functional groups can be synthesized. Through a series of 
repeating chemical synthesis on the core, the size and 
shape of dendrimers are determined by the generation. 
The key useful character of dendrimers is the branches 
which can provide vast amounts of surface area for drugs 
and targeting molecules. Meanwhile, the surface 
functionalities, interior branching, and chemical 
composition of the core play a significant role in 
reactivating the macromolecule Dendrimer is one of the 
most elegant nanotechnology platform s for targeted drug 
delivery. Conjugated with biotin as the targeting moiety, 
the in vitro targeting ability of partially acetylated 
generation 5 polyamidoamine (PAMAM) dendrimer 
(Ac-G5) in HeLa cells was assessed. The 
multi-functional conjugate Ac-G5-biotin-FITC 
(fluorescein isothiocyanate) showed much higher cellular 
uptake than the conjugate without biotin. The energy 
dependent uptake process can be blocked effectively by 
biotin polymer conjugates, exhibiting an expected dose 
response curve 13, 14. 
 
 
Figure 4: Structure of Dendrimers 
d. Nanoshells 
These are another recent invention. NS are miniscule 
beads coated with gold. By manipulating the thickness of 
the layers making up the NS, the beads can be designed 
that absorb specific wavelength of light. The most useful 
nanoshells are those that absorb near infrared light that 
can easily penetrate several centimeters in human tissues. 
Absorption of light by nanoshells creates an intense heat 
that is lethal to cells. Nanoshells can be linked to 
antibodies that recognize cancer cells. In laboratory 
cultures, the heat generated by the light-absorbing 
nanoshells has successfully killed tumor cells while 
leaving neighbouring cells intact 15. 
Sharma et al              JDDT; Special Issue1: "Drug Delivery using Nanomedicine & Nanotechnology"                69 
© 2011-14, JDDT. All Rights Reserved                                                ISSN: 2250-1177                                                CODEN (USA): JDDTAO 
 
Figure 5: Drug delivery system based on Nanoshells 
e. Carbon Nanotubes 
Carbon nanotubes are cylinders of one several coaxial 
graphite layers with a diameter in the order of 
nanometers, and they serve as instructive examples of the 
Janus-like properties of nanomaterials 16. They can be 
classified into two general categories based on their 
structure: single-walled carbon nanotubes (SWCNTs) 
with a single cylindrical carbon wall and multiwalled 
carbon nanotubes (MWCNTs) with multiple walls-
cylinders nested within other cylinders 17. Due to their 
unique electronic, thermal, and structural characteristics, 
they can offer a promising approach for gene and drug 
delivery for cancer therapy 18. Heating of organs and 
tissues by placing multifunctional nanomaterials at tumor 
sites is emerging as an art of tumor treatment by “Nano 
thermal Therapy”. Carbon nanotubes have become 
candidates to kill cancer cells via local hyperthermia, due 
to their thermal conductivity and optical properties 19. 
 
 
Figure 6:  Carbon Nanotubes (a) single walled carbon nanotube and (b) multiwalled carbon nanotube 
f. Quantum Dots 
Over the past few decades quantum dots (QDs) have 
been an area of intense research due to their unique 
physical properties that can be exploited for cancerous 
tumor detection.  QDs usually consist of an inorganic 
transition metal core/shell system, and the majority of 
QDs are made up of cadmium selenide (CdSe), cadmium 
telluride (CdTe), Indium phosphide (InP), and indium 
arsenide (InAs) as core elements inside a shell, usually 
zinc sulfide (ZnS). The major reasons that these 
inorganic-organic composite nanoparticles are extremely 
efficient agents for cancer detection in vivo are their 
small size, which gives them unhindered access to the 
systemic circulation, and at the same time their ability to 
conjugate targeting molecules that direct specific 
accumulation in neoplastic sites 20, 21. Additionally, 
similar to other nanoparticles, QDs have sufficient 
surface area to attach therapeutic agents and tumor 
specific moieties for simultaneous drug delivery and in-
vivo imaging and tissue engineering 22.Depending on 
size and the core/shell system, QDs have the ability to 
emit light across the visible and infrared wavelength 
spectrum, and thus one can choose a suitable color of 
light emission. The main advantage of the QDs is that 
with a single light source, the variously-sized QDs can 
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be excited while preserving the narrow emission of each 
individual particle/wavelength23. Additionally, QDs have 
the ability to incorporate different markers 
simultaneously (multiplexing), enabling numerous 
targets to be imaged in a single experiment 24.  
 
Figure 7: Schematic representation of Quantum Dots 
g. Nanowires 
A nanowire is a nanostructure, with the diameter of the 
order of a nanometer (10−9meters). Alternatively, 
nanowires can be defined as structures that have a 
thickness or diameter constrained to tens of nanometers 
or less and an unconstrained length. At these scales, 
quantum mechanical effects are important which coined 
the term "quantum wires". Many different types of 
nanowires exist, including metallic (e.g., Ni, Pt, Au), 
semiconducting (e.g., Si, InP, GaN, etc.), and insulating 
(e.g., SiO2, TiO2). Molecular nanowires are composed 
of repeating molecular units either organic (e.g. DNA) or 
inorganic. The nanowires could be used, in the near 
future, to link tiny components into extremely small 
circuits.  Using nanotechnology, such components could 
be created out of chemical compounds 25. 
 
Figure 8:  SEM of Nanowires 
 
h. Nano-Cantilevers 
Tiny bars anchored at one end can be engineered to bind 
to molecules associated with cancer. These molecules 
may bind to altered DNA proteins that are present in 
certain types of cancer. This will change the surface 
tension and cause the cantilevers to bend. By monitoring 
the bending of cantilevers, it would be possible to tell 
whether the cancer molecules are present and hence 
detect early molecular events in the development of 
cancer 15. 
i. Superparamagnetic nanoparticles 
Superparamagnetic nanoparticles refer to iron oxide 
particles or magnetite (Fe3O4) particles that are less 
than10 nm in diameter. They have been around for years 
as contrasting agents for magnetic resonance imaging 
(MRI). Many groups have explored the use of magnetic 
fields to localize magnetic nanoparticles to targeted sites, 
a system known as magnetic drug targeting. Iron oxide 
nanoparticles can be water-solubilized with hydrophilic 
polymer coatings, such as dextran or PEG. In fact, 
attaching PEG to nanoparticles in general, not just to iron 
oxide particles, is a well documented means of sterically 
preventing opsonization of nanoparticles in the serum 
and reducing their uptake by the reticuloendothelial 
system. This effectively enhances biocompatibility and 
increases the circulation time of nanoparticles 26. Iron 
oxide nanoparticles can also be made hydrophobic by 
coating with aliphatic surfactants or liposomes (resulting 
in magnetoliposomes) 27. Magnetic nanoparticles can be 
remotely activated using electromagnetic fields, and they 
can also be used to thermally treat cancers 28. Most 
recently, superparamagnetic nanoparticles have been 
used in clinical thermotherapy of locally recurrent 
prostate cancer. Thermotherapy is defined as the abilityto 
attain at least hyperthermic temperatures of up to 428 ºC, 
which can render cancer cells more susceptible to the 
effects of radiation and cause some apoptosis29. 
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CONCLUSION 
The introduction of nanotechnology in pharmaceutical 
sciences has revolutionized the delivery of drugs, 
allowing the emergence of new treatments with an 
improved specificity. Nanotechnology is now widely 
implanted in the move of revisiting drug delivery 
methods. These new nanosystems can be tailor-made 
according to the desired functions and duty thanks to 
parallel progresses in the synthesis of colloidal systems 
with perfectly controlled characteristics. Nanotechnology 
is definitely a medical boon for diagnosis, treatment and 
prevention of cancer disease.  It will radically change the 
way we diagnose, treat and prevent cancer to help meet 
the goal of eliminating suffering and death from cancer. 
The use of  nanotechnology has introduced greater 
flexibility  in  the  paradigm of cancer therapeutics and 
diagnostics by not only improving the efficacy, safety 
and tumour-targeting but by also aiding  in the reduction 
of the adverse effects, invasiveness and risks associated 
with conventional drug  therapy. The integration of 
nanotechnology into cancer diagnostics and therapeutics 
is a rapidly advancing field, and there is a need for wide 
understanding of these emerging concepts. The present 
paper reviews the use of nanotechnology as strategies to 
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deliver existing chemotherapies and novel therapeutic 
molecules in a controlled manner to malignancies. 
Developments in such areas as polymeric nanoparticles, 
nanoshells, carbon nanotubes, dendrimers, quantum dots, 
superparamagnetic nanoparticles, and liposomes are 
making early detection, prevention and treatment with a 
high degree of accuracy and ease possible. Also other 
recent discoveries and inventions in nanotechnology are 
suggesting that a safe and effective cure for cancer is just 
around the corner. 
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